Literature DB >> 16508713

Variations of pituitary function over time after brain injuries: the lesson from a prospective study.

Giulio Giordano1, Gianluca Aimaretti, Ezio Ghigo.   

Abstract

Traumatic Brain Injury (TBI) and Subarachnoid Haemorrhage (SAH) are conditions at high risk to develop hypopituitarism as pointed out by many papers in scientific literature. But most of the papers were referred to retrospective evaluations, not considering the possible evolution of the pituitary function over time. Aim of our studies was to clarify whether pituitary deficiencies and normal pituitary function recorded at short term follow-up (3 months), would improve or worsen, respectively, at long term (12 months after the brain injury). In a multicenter study protocol, in patients who suffered TBI (n = 70; 50 Males, 20 Females; age 39.31 +/- 2.4 years; BMI 23.8 +/- 0.4 kg/m(2)) or SAH (n = 32; 12M, 20F; age: 51.9 +/- 2.2 year; BMI: 24.7 +/- 0.6 kg/m(2)) we tested 3 and 12 months after the pathological events the pituitary function. In TBI patients, the 3 month evaluation had shown some degree of hypopituitarism in 32.8% and the 12 months retesting demonstrated some degree of hypopituitarism in 22.7%. Total hypopituitarism was always confirmed at 12 months while Multiple and Isolated deficits recorded at 3 months was confirmed in nearly 25% only of the patients. On the other hand, in 5.5% of TBI with normal pituitary function at 3 months Isolated deficits were recorded at 12 months testing. Moreover, in 13.3% of TBI with Isolated deficit at 3 months Multiple hypopituitarism was demonstrated at 12 months retesting. In SAH patients, the 3 months evaluation had shown some degree of hypopituitarism in 46.8% and the 12 month retesting demonstrated some degree of hypopituitarism in 37.5%. No multiple hypopituitarism recorded at 3 months was confirmed at 12 months, but 2 patients with isolated deficits at 3 months showed multiple hypopituitarism at 12 month retesting. At 12 as well as at 3 months, both in TBI and SAH patients, the most common deficit was severe GHD (>20%) followed by secondary hypogonadism and then hypoadrenalism and hypothyroidism. In all, in patients who experienced TBI or SAH the risk to develop hypopituitarism is very high; early diagnosis of total hypopituitarism is always confirmed at the long term follow-up; however pituitary function in brain injured patients may improve over time, because, isolated and even multiple pituitary insufficiencies recorded at short term can be transient; on the other hand normal pituitary function recorder at short term may, become impaired 12 months after the injury. Thus, brain injured patients must undergo neuroendocrine follow-up over time in order to monitoring pituitary function and eventually providing appropriate placement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16508713     DOI: 10.1007/s11102-006-6045-1

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  23 in total

Review 1.  Clinical review 113: Hypopituitarism secondary to head trauma.

Authors:  S Benvenga; A Campenní; R M Ruggeri; F Trimarchi
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

2.  Epidemiology of traumatic brain injury in Johannesburg--II. Morbidity, mortality and etiology.

Authors:  V Nell; D S Brown
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

3.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

Authors:  G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; E Arvat; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 4.  Pituitary insufficiency.

Authors:  S W Lamberts; W W de Herder; A J van der Lely
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

5.  Epidemiology of head injury.

Authors:  B Jennett; R MacMillan
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

6.  Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report.

Authors:  D F Kelly; I T Gonzalo; P Cohan; N Berman; R Swerdloff; C Wang
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

7.  Pituitary changes in head trauma (analysis of 102 consecutive cases of head injury).

Authors:  R Ceballos
Journal:  Ala J Med Sci       Date:  1966-04

Review 8.  Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults.

Authors:  E Ghigo; G Aimaretti; E Arvat; F Camanni
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

9.  Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin-releasing hormone and GH-releasing hormone.

Authors:  L De Marinis; A Mancini; D Valle; A Bianchi; R Gentilella; I Liberale; V Mignani; M Pennisi; F Della Corte
Journal:  Clin Endocrinol (Oxf)       Date:  1999-06       Impact factor: 3.478

10.  Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury.

Authors:  Gianluca Aimaretti; Maria Rosaria Ambrosio; Carolina Di Somma; Alessandra Fusco; Salvatore Cannavò; Maurizio Gasperi; Carla Scaroni; Laura De Marinis; Salvatore Benvenga; Ettore Carlo degli Uberti; Gaetano Lombardi; Franco Mantero; Enio Martino; Giulio Giordano; Ezio Ghigo
Journal:  Clin Endocrinol (Oxf)       Date:  2004-09       Impact factor: 3.478

View more
  13 in total

1.  Traumatic brain injury-mediated hypopituitarism. Report of four cases.

Authors:  Preamrudee Poomthavorn; Margaret Zacharin
Journal:  Eur J Pediatr       Date:  2007-01-17       Impact factor: 3.183

2.  Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury.

Authors:  Stefania Giuliano; Serafina Talarico; Lucia Bruno; Francesco Beniamino Nicoletti; Claudio Ceccotti; Antonino Belfiore
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

Review 3.  Endocrine function following acute SAH.

Authors:  Paul Vespa
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 4.  SAH pituitary adrenal dysfunction.

Authors:  P Vespa
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 5.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

6.  Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction.

Authors:  David J Barton; Raj G Kumar; Emily H McCullough; Gary Galang; Patricia M Arenth; Sarah L Berga; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2016 Jul-Aug       Impact factor: 2.710

Review 7.  Traumatic brain injury: endocrine consequences in children and adults.

Authors:  Erick Richmond; Alan D Rogol
Journal:  Endocrine       Date:  2013-09-13       Impact factor: 3.633

Review 8.  Cortisol levels and the severity and outcomes of acute stroke: a systematic review.

Authors:  Amanda Jayne Barugh; Paul Gray; Susan Deborah Shenkin; Alasdair Maurice Joseph MacLullich; Gillian Elizabeth Mead
Journal:  J Neurol       Date:  2014-01-30       Impact factor: 4.849

Review 9.  Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood.

Authors:  Ginevra Corneli; Valentina Gasco; Flavia Prodam; Silvia Grottoli; Gianluca Aimaretti; Ezio Ghigo
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

Review 10.  Impaired Pituitary Axes Following Traumatic Brain Injury.

Authors:  Robert A Scranton; David S Baskin
Journal:  J Clin Med       Date:  2015-07-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.